{
  "id": "6278dd4c56bf9aee6f000011",
  "type": "list",
  "question": "What datasets are available related to Duchenne Muscular Dystrophy?",
  "ideal_answer": "Using data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) Five sources of RWD/NHD were contributed by Universitaire Ziekenhuizen Leuven, DMD Italian Group, The Cooperative International Neuromuscular Research Group, ImagingDMD, and the PRO-DMD-01 study (n = 430 patients, in total).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24634239",
    "http://www.ncbi.nlm.nih.gov/pubmed/21836521",
    "http://www.ncbi.nlm.nih.gov/pubmed/28859693",
    "http://www.ncbi.nlm.nih.gov/pubmed/26356412",
    "http://www.ncbi.nlm.nih.gov/pubmed/28739181",
    "http://www.ncbi.nlm.nih.gov/pubmed/32611643",
    "http://www.ncbi.nlm.nih.gov/pubmed/32791870",
    "http://www.ncbi.nlm.nih.gov/pubmed/23382369",
    "http://www.ncbi.nlm.nih.gov/pubmed/30448867",
    "http://www.ncbi.nlm.nih.gov/pubmed/32692451",
    "http://www.ncbi.nlm.nih.gov/pubmed/22639722",
    "http://www.ncbi.nlm.nih.gov/pubmed/33918694",
    "http://www.ncbi.nlm.nih.gov/pubmed/28807723",
    "http://www.ncbi.nlm.nih.gov/pubmed/34877803",
    "http://www.ncbi.nlm.nih.gov/pubmed/19394035",
    "http://www.ncbi.nlm.nih.gov/pubmed/25338682",
    "http://www.ncbi.nlm.nih.gov/pubmed/34682100",
    "http://www.ncbi.nlm.nih.gov/pubmed/26981371",
    "http://www.ncbi.nlm.nih.gov/pubmed/34776418"
  ],
  "snippets": [
    {
      "text": "Using data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34776418",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five sources of RWD/NHD were contributed by Universitaire Ziekenhuizen Leuven, DMD Italian Group, The Cooperative International Neuromuscular Research Group, ImagingDMD, and the PRO-DMD-01 study (n = 430 patients, in total).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32611643",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " present study, we have first conducted a meta-analysis of three microarray datasets, GSE38417, GSE3307, and GSE6011, to identify the differentially expressed genes (DEGs) between healthy donors and DMD patients. We have the",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33918694",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The cohort comes from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), a multistate, multiple-source, population-based surveillance system that identifies and gathers information on all cases of Duchenne and Becker muscular dystrophy born since 1982.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19394035",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We used the data from the Japanese Registry of Muscular Dystrophy (Remudy)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28859693",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report the largest dystrophinopathies mutation dataset in Japan from a national patient registry, \"Remudy\"",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28859693",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The gene expression profile dataset GSE38417 of DMD was obtained from the Gene Expression Omnibus (GEO) database.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32791870",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "two microarray data sets obtained from the Gene Expression Omnibus database, we conducted a dysfunctional pathway-enrichment analysis and investigated deregulated genes that are specific to different phases of the disease in order to determine pathogenic characteristics in the progression of DMD. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634239",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Current methods to monitor DMD patient information (MD STARnet, DuchenneConnect, and TREAT-NMD)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382369",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A similar patient registry is under development for the Muscular Dystrophy Association (MDA) clinic network. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382369",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Duchenne Connect patient registry to provide information particularly in regard to active treatment choices in Duchenne muscular dystrophy and their impact on disease progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26356412",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "the case-control 4D-DMD study (Detection by Developmental Delay in Dutch boys with Duchenne Muscular Dystrophy), data on developmental milestones for 76 young males with DMD and 12\u00a0414 young males from a control group were extracted from the health care records of youth health care services. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32692451",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study examined three data sets, Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet); Dutch Natural History Survey (DNHS); and Parent Project Muscular Dystrophy (PPMD). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28739181",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The data have been deposited in the Gene Expression Omnibus (GEO) with the accession number GSE64420. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26981371",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "escalating dose pilot study (PRO051-02) with drisapersen. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30448867",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " in the escalating dose pilot study (PRO051-02)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30448867",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Data were integrated from past studies through the Duchenne Regulatory Science Consortium (D-RSC) founded by the Critical Path Institute, (15 clinical trials and studies, 1,505 subjects, 27,252 observations).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34877803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using two microarray datasets from Gene Expression Omnibus (GEO) database, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25338682",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "MD STARnet, Muscular Dystrophy Surveillance Tracking and Research Network, ImagingDMD, PRO-DMD-01, PRO051-02, D-RSC data, Duchenne Regulatory Science Consortium database, Japanese Registry of Muscular Dystrophy (Remudy), Remudy, Japanese Registry of Muscular Dystrophy, GSE38417, DuchenneConnect, TREAT NMD, Muscular Dystrophy Association (MDA), MDA Registry, Muscular Dystrophy Association Registry, 4D-DMD study, Dutch Natural History Survey, DNHS, PPMD, Parent Project Muscular Dystrophy, GSE64420, DMD Italian Group"
}